Published • loading... • Updated
FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
Summary by Carroll County Mirror-Democrat
2 Articles
2 Articles
The Norfolk Daily NewsReposted by 
Carroll County Mirror-Democrat
Carroll County Mirror-DemocratFibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
Company continues to advance CYWC628 manufacturing with second GMP drug product run released for shipment to Australia
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
